These data suggest a critical role of lncRNA H19 in the skeletal muscle during diabetes where, by altering HDAC6 levels, it modulates IRS1 levels and this might be one of the critical axes responsible for aberrant skeletal muscle physiology during diabetes. The gene discussed is IRS1; the disease is diabetes mellitus.